AI Verdict
SYK has stronger fundamentals based on our AI analysis.
REGN vs SYK Fundamental Comparison
| Metric | REGN | SYK |
|---|---|---|
| Revenue | $14.3B | $25.1B |
| Net Income | $4.5B | $3.2B |
| Net Margin | 31.4% | 12.9% |
| ROE | 14.4% | 14.5% |
| ROA | 11.1% | 6.8% |
| Current Ratio | 4.13x | 1.89x |
| Debt/Equity | 0.06x | 0.66x |
| EPS | $41.48 | $8.40 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
REGN vs SYK: Frequently Asked Questions
Is REGN or SYK a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), SYK has stronger fundamentals. REGN is rated BUY (80% confidence) while SYK is rated BUY (86% confidence). This is not investment advice.
How does REGN compare to SYK fundamentally?
REGENERON PHARMACEUTICALS, INC. has ROE of 14.4% vs STRYKER CORP's 14.5%. Net margins are 31.4% vs 12.9% respectively.
Which stock pays higher dividends, REGN or SYK?
REGN has a dividend yield of N/A or no dividend while SYK has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in REGN or SYK for long term?
For long-term investing, consider that REGN has BUY rating with 80% confidence, while SYK has BUY rating with 86% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about REGN vs SYK?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For REGN vs SYK, the AI consensus favors SYK based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.